Cabot (CBT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for March 13, 2025, to be held virtually; shareholders will vote on four key proposals, including director elections, executive compensation, a new long-term incentive plan, and auditor ratification.
Board recommends voting FOR all proposals and nominees; voting is open to shareholders of record as of January 15, 2025.
Company highlights strong fiscal 2024 performance, achieving top-end growth targets, robust cash flow, and significant returns to shareholders.
Strategic initiatives advanced include sustainability-focused product launches, capacity expansions, and a $50 million DOE grant for battery materials.
Voting matters and shareholder proposals
Four directors nominated for election to serve until 2028: Michael M. Morrow, Thierry Vanlancker, Michelle E. Williams, and Frank A. Wilson.
Advisory vote on executive compensation (say-on-pay) and approval of the 2025 Long-Term Incentive Plan.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal 2025.
Board recommends FOR all proposals; voting can be done online, by phone, or by mail.
Board of directors and corporate governance
Board consists of 12 members, with a focus on diversity, independence, and relevant industry expertise.
Non-Executive Chair structure in place; all committees composed of independent directors.
Board refreshment ongoing, with three new directors in the last three years and a focus on skills, diversity, and tenure.
Governance Committee oversees director nominations, board evaluations, and related party transactions.
Latest events from Cabot
- Adjusted EPS down 13% to $1.53; Battery Materials up 39%, Reinforcement Materials EBIT down 22%.CBT
Q1 20264 Feb 2026 - Q3 adjusted EPS up 35% year-over-year; FY2024 guidance raised on strong segment growth.CBT
Q3 20242 Feb 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CBT
Proxy Filing27 Jan 2026 - Virtual meeting to elect directors, approve pay, and ratify auditor, with strong ESG focus.CBT
Proxy Filing27 Jan 2026 - 31% EPS growth, $265M returned to shareholders, and 2025 EPS guidance of $7.40–$7.80.CBT
Q4 202416 Jan 2026 - FY24 adjusted EPS guidance raised to $7.00–$7.10, driven by battery, E2C, and inkjet growth.CBT
Investor Day 202412 Jan 2026 - Adjusted EPS up 13% to $1.76; net income and cash flow drive strong shareholder returns.CBT
Q1 20259 Jan 2026 - Key votes include director elections, executive pay, incentive plan, and auditor ratification.CBT
Proxy Filing1 Dec 2025 - Q3 FY25 Adjusted EPS was $1.90, with mixed segment results and strong cash flow.CBT
Q3 202523 Nov 2025